(BNS) Bank of Nova Scotia - Ratings and Ratios
Banking, Loans, Mortgages, Investments, Insurance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.23% |
| Yield on Cost 5y | 9.62% |
| Yield CAGR 5y | 4.12% |
| Payout Consistency | 93.9% |
| Payout Ratio | 44.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 17.1% |
| Value at Risk 5%th | 27.9% |
| Relative Tail Risk | -1.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.14 |
| Alpha | 36.55 |
| CAGR/Max DD | 0.90 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.492 |
| Beta | 0.392 |
| Beta Downside | 0.237 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.53% |
| Mean DD | 7.11% |
| Median DD | 7.63% |
Description: BNS Bank of Nova Scotia December 03, 2025
The Bank of Nova Scotia (NYSE:BNS) is a diversified Canadian bank with operations across North America, Latin America, the Caribbean, and select international markets. It serves retail and commercial customers through four segments-Canadian Banking, International Banking, Global Wealth Management, and Global Banking & Markets-offering a full suite of products from deposit accounts and credit cards to mortgages, business loans, trade finance, and wealth-management services.
As of its latest earnings release (Q3 2024), BNS reported a net income of CAD 3.2 billion and a Common Equity Tier 1 (CET1) ratio of 13.1%, comfortably above the regulatory minimum. The bank’s earnings are highly sensitive to the North American interest-rate environment and to commodity-linked activity in its Latin-American operations, both of which have shown volatility in 2024. Digital adoption continues to accelerate, with mobile-banking transactions now representing roughly 55% of total retail activity, a trend that could improve cost efficiency if sustained.
For a deeper, data-driven assessment of BNS’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (7.79b TTM) > 0 and > 6% of Revenue (6% = 4.39b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -0.70pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1289 % (prev -1425 %; Δ 135.5pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 5.41b <= Net Income 7.79b (YES >=105%, WARN >=100%) |
| Net Debt (438.06b) to EBITDA (11.74b) ratio: 37.33 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.25b) change vs 12m ago 0.81% (target <= -2.0% for YES) |
| Gross Margin 44.25% (prev 28.65%; Δ 15.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 5.10% (prev 4.61%; Δ 0.48pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.28 (EBITDA TTM 11.74b / Interest Expense TTM 36.08b) >= 6 (WARN >= 3) |
Altman Z'' -4.00
| (A) -0.65 = (Total Current Assets 123.06b - Total Current Liabilities 1066.66b) / Total Assets 1460.04b |
| (B) 0.04 = Retained Earnings (Balance) 58.92b / Total Assets 1460.04b |
| (C) 0.01 = EBIT TTM 10.13b / Avg Total Assets 1436.03b |
| (D) 0.06 = Book Value of Equity 76.93b / Total Liabilities 1371.45b |
| Total Rating: -4.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 48.96
| 1. Piotroski 2.0pt |
| 2. FCF Yield 0.97% |
| 3. FCF Margin 6.91% |
| 4. Debt/Equity 5.80 |
| 5. Debt/Ebitda 37.33 |
| 6. ROIC - WACC (= -0.48)% |
| 7. RoE 9.15% |
| 8. Rev. Trend 86.30% |
| 9. EPS Trend -37.75% |
What is the price of BNS shares?
Over the past week, the price has changed by +3.64%, over one month by +11.25%, over three months by +17.03% and over the past year by +46.25%.
Is BNS a buy, sell or hold?
- Strong Buy: 4
- Buy: 0
- Hold: 10
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the BNS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67 | -9.6% |
| Analysts Target Price | 67 | -9.6% |
| ValueRay Target Price | 86 | 16% |
BNS Fundamental Data Overview December 20, 2025
P/E Trailing = 17.528
P/E Forward = 12.285
P/S = 2.837
P/B = 1.5819
P/EG = 1.5706
Beta = 1.278
Revenue TTM = 73.18b CAD
EBIT TTM = 10.13b CAD
EBITDA TTM = 11.74b CAD
Long Term Debt = 38.15b CAD (from longTermDebt, last quarter)
Short Term Debt = 301.49b CAD (from shortTermDebt, last quarter)
Debt = 504.02b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 438.06b CAD (from netDebt column, last quarter)
Enterprise Value = 519.75b CAD (123.82b + Debt 504.02b - CCE 108.10b)
Interest Coverage Ratio = 0.28 (Ebit TTM 10.13b / Interest Expense TTM 36.08b)
FCF Yield = 0.97% (FCF TTM 5.06b / Enterprise Value 519.75b)
FCF Margin = 6.91% (FCF TTM 5.06b / Revenue TTM 73.18b)
Net Margin = 10.64% (Net Income TTM 7.79b / Revenue TTM 73.18b)
Gross Margin = 44.25% ((Revenue TTM 73.18b - Cost of Revenue TTM 40.79b) / Revenue TTM)
Gross Margin QoQ = 46.50% (prev 46.16%)
Tobins Q-Ratio = 0.36 (Enterprise Value 519.75b / Total Assets 1460.04b)
Interest Expense / Debt = 1.71% (Interest Expense 8.63b / Debt 504.02b)
Taxrate = 22.92% (656.0m / 2.86b)
NOPAT = 7.81b (EBIT 10.13b * (1 - 22.92%))
Current Ratio = 0.12 (Total Current Assets 123.06b / Total Current Liabilities 1066.66b)
Debt / Equity = 5.80 (Debt 504.02b / totalStockholderEquity, last quarter 86.87b)
Debt / EBITDA = 37.33 (Net Debt 438.06b / EBITDA 11.74b)
Debt / FCF = 86.57 (Net Debt 438.06b / FCF TTM 5.06b)
Total Stockholder Equity = 85.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.53% (Net Income 7.79b / Total Assets 1460.04b)
RoE = 9.15% (Net Income TTM 7.79b / Total Stockholder Equity 85.10b)
RoCE = 8.22% (EBIT 10.13b / Capital Employed (Equity 85.10b + L.T.Debt 38.15b))
RoIC = 2.05% (NOPAT 7.81b / Invested Capital 381.61b)
WACC = 2.53% (E(123.82b)/V(627.85b) * Re(7.46%) + D(504.02b)/V(627.85b) * Rd(1.71%) * (1-Tc(0.23)))
Discount Rate = 7.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 1.39%
[DCF Debug] Terminal Value 76.38% ; FCFE base≈8.96b ; Y1≈7.94b ; Y5≈6.61b
Fair Price DCF = 96.93 (DCF Value 119.83b / Shares Outstanding 1.24b; 5y FCF grow -14.04% → 3.0% )
EPS Correlation: -37.75 | EPS CAGR: -2.84% | SUE: 0.68 | # QB: 0
Revenue Correlation: 86.30 | Revenue CAGR: 24.70% | SUE: 4.0 | # QB: 4
EPS next Quarter (2026-01-31): EPS=1.95 | Chg30d=+0.013 | Revisions Net=+0 | Analysts=13
EPS current Year (2026-10-31): EPS=8.05 | Chg30d=+0.115 | Revisions Net=+10 | Growth EPS=+13.5% | Growth Revenue=+3.5%
EPS next Year (2027-10-31): EPS=9.01 | Chg30d=+0.023 | Revisions Net=+3 | Growth EPS=+12.0% | Growth Revenue=+5.2%
Additional Sources for BNS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle